High-Purity Methyl N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valinate: A Key Pharmaceutical Intermediate
Essential for synthesizing vital therapeutic agents, this high-purity intermediate is a cornerstone of modern pharmaceutical production.
Get a Quote & SampleProduct Core Value
![Methyl N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valinate](https://www.nbinno.com/webimg/gemini_688bd0f82bad7_1753993464.png)
Methyl N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valinate
This high-quality compound, identified by CAS number 137863-89-9, serves as a critical pharmaceutical intermediate. Its primary role lies in the intricate synthesis pathways of angiotensin II type 1 receptor antagonists, a class of drugs vital for managing cardiovascular conditions.
- Explore the synthesis of valsartan impurity K to understand its critical role in drug purity.
- This pharmaceutical intermediate synthesis is designed for efficiency and high yield.
- Leveraging a biphenyl derivative structure, it's a key component in complex organic synthesis.
- As a vital API precursor sourcing component, it ensures reliable production of essential medications.
Advantages Offered
Exceptional Purity
With a purity of 98% minimum, this compound ensures the integrity and efficacy of the final pharmaceutical products, making it a reliable choice for critical applications.
Versatile Intermediate
As a key intermediate for receptor antagonists, its application in pharmaceutical intermediate synthesis highlights its broad utility in drug development.
Bulk Availability
The product is available in various bulk packaging options, catering to the large-scale demands of the pharmaceutical manufacturing sector.
Key Applications
Pharmaceutical Synthesis
Crucial for the synthesis of advanced pharmaceuticals, particularly in the creation of cardiovascular medications. This aligns with the need for precise API precursor sourcing.
Drug Impurity Studies
Serves as a reference standard in studies related to drug impurities, such as understanding the synthesis of valsartan impurity K, ensuring drug quality.
Specialty Chemical Manufacturing
Its unique biphenyl derivative structure makes it valuable in custom organic synthesis projects requiring complex molecular architectures.
Cardiovascular Therapeutics Development
Essential in the research and development of new angiotensin II type 1 receptor antagonists, contributing to novel treatments for hypertension and heart failure.